Serious Hyperkalemia (Figure 8)
Serious hyperkalemia was assessed by examining two outcomes: serious hyperkalemia and hyperkalemia-related hospitalization. The above-mentioned outcomes were reported in five out of seven studies [5,10,14-16], and the pooled analysis revealed that treatment with Finerenone was associated with a significantly increased risk of serious hyperkalemia and hospitalization due to hyperkalemia (RR = 4.25 [3.11, 5.83] p 0. 00001; I2= 0%) and (RR = 5.94 [4.04, 8.75] p 0. 00001; I2= 0%), respectively.